Quest Diagnostics Raises FY26 Guidance on Q3 Results; Shares Flat Pre-Market

Quest Diagnostics Inc. (DGX) raised its full-year 2026 earnings and revenue guidance Thursday while reporting third-quarter financial results, lifting its profit outlook on stronger expected revenue. For fiscal 2026, the diagnostic services firm now projects earnings of $10.21 to $10.31 per share and adjusted earnings of $11.25 to $11.35 per share on revenue of $12.065 billion to $12.105 billion. It previously guided earnings of $9.97 to $10.17 per share and adjusted earnings of $11.05 to $11.25 per share on revenue of $11.95 billion to $12.05 billion. Shares of DGX traded at $238.90 on the NYSE in Thursday's pre-market session, down $0.03, or 0.01 percent.